Table: begin end state 1 18 non-cytoplasmic 19 47 transmembrane 48 58 cytoplasmic 59 82 transmembrane 83 109 non-cytoplasmic 110 135 transmembrane 136 142 cytoplasmic 143 161 transmembrane 162 166 non-cytoplasmic 167 185 transmembrane 186 194 cytoplasmic 195 215 transmembrane 216 261 non-cytoplasmic 262 283 transmembrane 284 320 cytoplasmic 321 347 transmembrane 348 358 non-cytoplasmic 359 382 transmembrane 383 393 cytoplasmic 394 411 transmembrane 412 437 non-cytoplasmic 438 453 transmembrane 454 471 non-cytoplasmic 472 493 transmembrane 494 506 cytoplasmic
Input: >WP_086509281.1 NCBI__GCF_002151265.1:WP_086509281.1 MIDAFLVALNGVIEPYTLLLMAIGALAGIVSAAIPGFTITMAIVLTLPLTFAMPPLQGIA VMLSVYVGGLSGGLFSAALLGIPGTPSSVATTFDAFPMARSGLPGKALALGLWSSFFGSL ISIVVLILAAPPLALLAVKLGPWEYFALIVFALTVIASLVGDSLLRGLIAGLVGIGLATV GPDPLMGRERFTFGYEMLSAGIPFLVVLIGMYAVSQLLSELETSPKQQAQGSTSLISGDM RPHNLETLKAIVLRPVNVIRSSLIGVFIGAVPGAGSSISNLLAYDQAKRSSSHPENFGKG EPQGVIASESGNSSTAGGGLIPLIALGIPGSAVDAVLMAAIMVHGISIGPRLILDNPELV YGMFLSMAVASVLMLCIGLLLMRAFLNLLNVPKYFIVPVVLSCCVIGAFTLNNRITDLYL LAGVGVVGYLFKKLDYPLAPLVLGVVLGPIAETNLRRAFQTSTDWTLFFTRPISAALLAL AVASIVYSIVAYLRRSRPSSIPDSTT
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server